Skip to main content
Premium Trial:

Request an Annual Quote

DNAnexus, Deloitte Win $20M Contract to Run Multi-Omics on PrecisionFDA

NEW YORK – The US Food and Drug Administration has awarded a five-year, $20 million contract to the team of DNAnexus and Deloitte to run the collaborative omics environment for the PrecisionFDA cloud-based next-generation sequencing platform.

San Francisco-based DNAnexus has been leading the development of the PrecisionFDA data platform since 2015.

As part of the new contract, which DNAnexus announced Tuesday, the company and its partner Deloitte will add support for multi-omics data and provide a series of cloud-based analytical, statistical, and machine learning applications to the PrecisionFDA platform. 

"Recent scientific and biomedical advances in precision medicine are driving cloud-based data and technology strategies, closing the gap in our ability to translate advances into clinically validated diagnostics and therapeutics," Elaine Johanson, acting director of health informatics in FDA's within the Office of the Chief Scientist, said in a statement. "PrecisionFDA contributes to an optimized and independent review process by making tools available that empower reviewers to assess the accuracy of analytic pipelines without requiring bioinformatics expertise and enabling effective sponsor-reviewer interaction on a secure, cloud-based platform."

DNAnexus CEO Richard Daly said that the new contract demonstrates his company's understanding of "FDA's evolving needs for data stewardship, security, and quality, and the increasing complexity of bioinformatics in regulatory review." He said that the expanded relationship will help PrecisionFDA "enhance the regulatory process and provide better options for patients and healthcare providers."

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.